tiprankstipranks
Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
US Market

Elite Pharmaceuticals (ELTP) Income Statement

Compare
294 Followers

Elite Pharmaceuticals Income Statement

Last quarter (Q3 2025), Elite Pharmaceuticals's total revenue was $14.36M, a decrease of -7.56% from the same quarter last year. In Q3, Elite Pharmaceuticals's net income was $-10.89M. See Elite Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
$ 56.63M$ 34.16B$ 32.26M$ 25.38M$ 17.99M
Gross Profit
$ 26.36M$ 16.59B$ 14.80M$ 11.87M$ 7.98M
Operating Expenses
$ 15.57M$ 12.92B$ 9.72M$ 9.76M$ 10.26M
Depreciation and Amortization
$ 1.47M$ 1.33M$ 1.42M$ 1.52M$ 1.51M
EBITDA
$ 2.58M$ 6.43M$ 6.27M$ 5.93M$ -371.88K
Operating Income
$ 10.79M$ 2.03B$ 5.07M$ 2.10M$ -2.29M
Other Income/Expenses
$ -10.33M$ 309.87K$ 1.23M$ 2.04M$ 47.06K
Pretax Income
$ 463.09K$ 3.99B$ 6.30M$ 4.14M$ -2.24M
Net Income
$ 20.11M$ 4.41B$ 8.90M$ 5.09M$ -2.24M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.02$ 4.35$ 0.01$ 0.01$ 0.00
Diluted EPS
$ 0.02$ 4.35$ 0.01$ 0.01$ 0.00
Weighted Average Shares Outstanding
1.02B 1.01B 1.01B 943.00M 832.33M
Weighted Average Shares Outstanding (Diluted)
1.02B 1.01B 1.01B 943.00M 832.33M
Currency in USD

Elite Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis